1. A therapeutic or prophylactic agent for diseases caused by disorders of glucose metabolism, comprising as active ingredient 2-phenylthiazole derivative represented by the following formula (I), or a pharmaceutically acceptable salt thereof The compound 1c formuleRpredstavlyaet a specified (CC) alkoxy group, a morpholino group , 4-methylpiperazin-1-yl group or a piperidino group, R is nitro or cyano, X represents a carboxyl group or a (C-C) alkoxycarbonyl group, Y Representat ulation hydrogen atom or (C-C) alkyl gruppu.2. A therapeutic or preventive agent according to Claim. 1, wherein the disease caused by impaired glucose metabolism, is a sugar diabet.3. The therapeutic or prophylactic of claim. 2, wherein the diabetes is diabetes type 2.4. A therapeutic or preventive agent according to Claim. 1, wherein the disease caused by impaired glucose metabolism, represents insulinorezistentnost.5. A therapeutic or preventive agent according to Claim. 1, wherein the disease caused by impaired glucose metabolism is impaired glyukozy.6 tolerability. A therapeutic or preventive agent according to Claim. 1 wherein a therapeutic or prophylactic agent for diseases caused by disorders of glucose metabolism, hypoglycemic represents sredstvo.7. A therapeutic or prophylactic agent according to any one of claims. 1-6, where the 2-phenylthiazole derivative represented by formula (I) above, is 2- (3-cyano-4-isobutyloxyphenyl) -4-methyl-5-tiazolkarbonovuyukislotu or a pharmaceutically acceptable salt thereof.1. Терапевтическое или профилактическое средство против заболеваний, вызванных нарушениями обмена глюкозы, включающее в качестве активного ингредиента производное 2-фенилтиазола, представленное приведенной далее формулой (I), или его фармацевтически приемлемую сольСоединение 1в указанной формулеR1 представляет собой (C1-C8)алкоксигруппу, морфолино группу, 4-метилпиперазин-1-ильную группу или пиперидиногруппу,R2 представляет собой нитрогруппу или цианогруппу,X представляет собой ка
